Repeat positive SARS-CoV-2 RNA testing in nursing home residents during the initial 9 months of the COVID-19 pandemic: an observational retrospective analysis
Armstrong JN, Campbell L, Rabatsky-her T, Leung V, Parikh S. Repeat positive SARS-CoV-2 RNA testing in nursing home residents during the initial 9 months of the COVID-19 pandemic: an observational retrospective analysis. The Lancet Regional Health - Americas 2021, 3: 100054. PMID: 34458887, PMCID: PMC8380052, DOI: 10.1016/j.lana.2021.100054.Peer-Reviewed Original ResearchRepeat positive testNursing home residentsPositive testHome residentsNursing homesSARS-CoV-2 RNA testingInitial positive test resultNegative RT-PCR testSARS-CoV-2 testingInitial positive testObservational retrospective analysisNursing home populationCOVID-19 vaccinationPositive test resultsYounger age groupsSARS-CoV-2 diagnosisSARS-CoV-2RT-PCR testPublic health guidanceInitial positive resultsNursing home casesMultiple comorbiditiesMedian timeProtective immunityRNA testingEffectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks — Connecticut, December 2020–February 2021
Britton A, Slifka K, Edens C, Nanduri SA, Bart S, Shang N, Harizaj A, Armstrong J, Xu K, Ehrlich HY, Soda E, Derado G, Verani JR, Schrag SJ, Jernigan JA, Leung VH, Parikh S. Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks — Connecticut, December 2020–February 2021. MMWR Morbidity And Mortality Weekly Report 2021, 70: 396-401. PMID: 33735160, PMCID: PMC7976620, DOI: 10.15585/mmwr.mm7011e3.Peer-Reviewed Original ResearchConceptsPfizer-BioNTech COVID-19 vaccineSkilled nursing facilitiesCOVID-19 vaccineLong-term care facilitiesSNF residentsNursing facilitiesCOVID-19 vaccine clinical trialsCOVID-19-associated morbidityEarly COVID-19 vaccinationSARS-CoV-2 infectionElectronic chart reviewVaccine effectiveness dataUnderlying medical conditionsVaccine clinical trialsCOVID-19 vaccinationPfizer-BioNTech vaccineSARS-CoV-2Long-term care programsStaff membersChart reviewFirst doseVaccination statusPartial vaccinationVaccine impactSecond dose